• Date: November 14, 2017

Back in 1991, 14 November was the date set by the International Diabetes Federation and the World Health Organisation for World Diabetes Day. The event is the largest campaign of its kind to raise awareness of the metabolic disease, and reaches over 1 billion people worldwide.


One of the objectives of CaixaImpulse is to promote research transfer to the market in order to improve people’s health. Diabetes is a several complex condition affecting the quality of life of many people worldwide. In general, diabetes patients are to some extent unable to control the amount of sugar levels in their blood, and this is the focus of most treatments. However, this treatment results in some patients developing fatty liver disease.


Finding a new treatment for diabetic patients with associated fatty liver disease is one of the objectives of the APODRUG project. The project took part in CaixaImpulse in 2016, and is led by scientists from the Center for Applied Medical Research (CIMA) at the University of Navarra.

More programme highlights

June 21, 2018

“SMuFin detects genomic mutations of all kinds more efficiently than other software programs”

Founded at the Barcelona Supercomputing Centre, SMuFin is a software program that offers promising advances in personalised medicine. We spoke to Ezequiel Mas, the project manager during CaixaImpulse, to find out more.

May 31, 2018

The KAMLEON project receives a number of awards

Founded at the Rovira i Virgili University, KAMLEON is developing a cloud platform capable of monitoring hydration levels through urine and sweat sensors.

May 03, 2018

Three editions of CaixaImpulse at a glance

When the call for proposals for the fourth edition of CaixaImpulse just closed, it is a good chance to take stock of what previous editions of the programme have meant.